PMID,Title,Journal,Year
38732190,A Systematic Review of Semaglutide's Influence on Cognitive Function in Preclinical Animal Models and Cell-Line Studies.,International journal of molecular sciences,2024
38566910,Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database.,Therapeutic advances in neurological disorders,2024
37460968,Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension.,The journal of headache and pain,2023
36584570,"Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: Involvement of the PI3K/Akt/GSK-3beta pathway.",International immunopharmacology,2023
